NYSE:CHE Chemed (CHE) Stock Price, News & Analysis $512.86 +17.21 (+3.47%) Closing price 09/25/2026 03:59 PM EasternExtended Trading$508.02 -4.84 (-0.94%) As of 09/25/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Chemed Stock (NYSE:CHE) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Chemed alerts:Sign Up Key Stats Today's Range$498.79▼$514.5150-Day Range$495.57▼$552.2852-Week Range$365.20▼$557.00Volume233,283 shsAverage Volume136,840 shsMarket Capitalization$6.70 billionP/E Ratio25.76Dividend Yield0.55%Price Target$554.60Consensus RatingHold Company Overview Chemed Corporation is a diversified holding company that operates businesses in the healthcare and residential and commercial services industries. Its primary operations are conducted through VITAS Healthcare and Roto-Rooter. VITAS Healthcare provides hospice and palliative care for patients with advanced illnesses. Its services are delivered in patients’ homes, hospice residences, nursing facilities, hospitals and other care settings, primarily throughout the United States. Care is provided by interdisciplinary teams that may include physicians, nurses, hospice aides, social workers and chaplains. Roto-Rooter provides plumbing and drain-cleaning services, as well as water cleanup and related services for residential and commercial customers. Its offerings include sewer and drain cleaning, plumbing repair and installation, water damage mitigation and emergency response. Roto-Rooter serves customers across the United States and Canada through company-operated locations and a franchise network. Chemed traces its origins to 1970 and has developed its business through the ownership and operation of service companies in healthcare and home services. The company is led by President and Chief Executive Officer Kevin J. McNamara.AI Generated. May Contain Errors. Read More Chemed Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks69th Percentile Overall ScoreCHE MarketRank™: Chemed scored higher than 69% of companies evaluated by MarketBeat, and ranked 259th out of 908 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.8 / 5Analyst RatingHold Consensus RatingChemed has received a consensus rating of Hold. The company's average rating score is 2.29, and is based on no strong buy ratings, 2 buy ratings, 5 hold ratings, and no sell ratings.Upside/DownsideThe consensus price target for Chemed is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoverageChemed has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Chemed's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth6.88% Earnings GrowthEarnings for Chemed are expected to grow by 6.88% in the coming year, from $23.55 to $25.17 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Chemed is 25.76, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.64.Price to Earnings Ratio vs. SectorThe P/E ratio of Chemed is 25.76, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 274.41.Price to Earnings Growth RatioChemed has a PEG Ratio of 1.99. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioChemed has a P/B Ratio of 7.42. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Chemed's valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted5.17% of the float of Chemed has been sold short.Short Interest Ratio / Days to CoverChemed has a short interest ratio ("days to cover") of 5.4.Change versus previous monthShort interest in Chemed has recently increased by 15.70%, indicating that investor sentiment is decreasing significantly. Dividend3.3 / 5Dividend StrengthStrong Dividend YieldChemed has a dividend yield of 0.56%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthChemed has been increasing its dividend for 16 years.Dividend CoverageThe dividend payout ratio of Chemed is 14.06%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Chemed will have a dividend payout ratio of 11.12% next year. This indicates that Chemed will be able to sustain or increase its dividend.Read more about Chemed's dividend. News and Social Media2.8 / 5News Sentiment0.49 News SentimentChemed has a news sentiment score of 0.49. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.73 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 15 news articles for Chemed this week, compared to 4 articles on an average week.Search Interest2 people have searched for CHE on MarketBeat in the last 30 days. Company Ownership1.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Chemed insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $3,806,260.00 in company stock.Percentage Held by Insiders3.33% of the stock of Chemed is held by insiders.Percentage Held by Institutions95.85% of the stock of Chemed is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Chemed's insider trading history. Receive CHE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Chemed and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CHE Stock News HeadlinesUBS initiates coverage of Chemed with buy2 hours ago | msn.comChemed Corporation (NYSE:CHE) Receives Average Recommendation of "Hold" from AnalystsSeptember 23 at 4:59 AM | americanbankingnews.comElon’s AI Phone is comingRumors are swirling that Elon Musk is developing a new mobile device that could rival the iPhone. It's said to be thinner, longer-lasting on battery, and cheaper to produce, with the ability to work worldwide without relying on cell towers. Former Bloomberg reporter and SAC Capital trader Josh Baylin says the evidence is mounting. He notes the FCC recently gave Musk a green light connected to his mobile plans, adding fuel to speculation. Baylin previously called the smartphone boom in 2004 and predicted Apple would sell a billion phones when others expected a fraction of that. | Stansberry Research (Ad)Chemed (CHE) Buys a $60.6M Roto-Rooter Franchise. Can Ownership Lift Returns?September 22, 2026 | insidermonkey.comCritical Analysis: Chemed (CHE) and The CompetitionSeptember 22, 2026 | americanbankingnews.comChemed (NYSE:CHE) CEO Sells 2,000 SharesSeptember 22, 2026 | insidertrades.comTop Chemed Insider Cashes In on a Major Stock MoveSeptember 21, 2026 | tipranks.comChemed Insider Sold Shares Worth $1,002,800, According to a Recent SEC FilingSeptember 21, 2026 | marketscreener.comMSee More Headlines CHE Stock Analysis - Frequently Asked Questions How have CHE shares performed this year? Chemed's stock was trading at $427.86 on January 1st, 2026. Since then, CHE shares have increased by 19.9% and is now trading at $512.8620. How were Chemed's earnings last quarter? Chemed Corporation (NYSE:CHE) posted its earnings results on Tuesday, July, 28th. The company reported $6.06 EPS for the quarter, topping analysts' consensus estimates of $5.60 by $0.46. The firm's revenue for the quarter was up 8.8% compared to the same quarter last year. Read the conference call transcript. Who are Chemed's major shareholders? Chemed's top institutional shareholders include BlackRock Inc. (11.36%), Bank of America Corp DE (0.79%), Caisse de depot et placement du Quebec (0.73%) and Bank of New York Mellon Corp (0.72%). Insiders that own company stock include Kevin J Mcnamara, Spencer S Lee, David Patrick Williams, Andrea R Lindell, Patrick P Grace, George J Walsh III, Michael D Witzeman, Brian C Judkins and Nicholas Michael Westfall. View institutional ownership trends. How do I buy shares of Chemed? Shares of CHE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Chemed own? Based on aggregate information from My MarketBeat watchlists, some other companies that Chemed investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), DiamondRock Hospitality (DRH) and AUO (AUOTY). Company Calendar Last Earnings7/28/2026Record date for 9/3 Dividend8/17/2026Ex-Dividend for 9/3 Dividend8/17/2026Dividend Payable9/03/2026Today9/25/2026Next Earnings (Estimated)10/27/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (2d) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 As of 2 days ago, CHE's financial health entered the Yellow zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryHealthcare Services Current SymbolNYSE:CHE CIK19584 Webwww.chemed.com Phone(513) 762-6690Fax513-762-6590Employees15,811Year Founded1970Price Target and Rating Average Price Target for Chemed$554.60 High Price Target$650.00 Low Price Target$475.00 Potential Upside/Downside+8.1%Consensus RatingHold Rating Score (0-4)2.29 Research Coverage7 Analysts Profitability EPS (Trailing Twelve Months)$19.91 Trailing P/E Ratio25.76 Forward P/E Ratio21.78 P/E Growth1.99Net Income$265.24 million Net Margins10.60% Pretax Margin14.23% Return on Equity31.77% Return on Assets18.90% Debt Debt-to-Equity Ratio0.17 Current Ratio0.91 Quick Ratio0.89 Sales & Book Value Annual Sales$2.53 billion Price / Sales2.65 Cash Flow$25.53 per share Price / Cash Flow20.09 Book Value$69.15 per share Price / Book7.42Miscellaneous Outstanding Shares13,070,000Free Float12,635,000Market Cap$6.70 billion OptionableOptionable Beta0.51 Social Links (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free Report This page (NYSE:CHE) was last updated on 9/26/2026 by MarketBeat.com Staff. From Our PartnersA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredShocking new footage just releasedGerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...Digest Publishing | SponsoredMajor Buy Alert Issued for September 30thKeith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...TradeSmith | SponsoredTrump goes "all-in" on Grand Canyon energy breakthroughA drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...Behind the Markets | SponsoredThe retirement stock I'd buy before Nvidia todayIn 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Ch...Chaikin Analytics | SponsoredThis free guide explains options the way they should be taughtMost options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...Base Camp Trading | SponsoredA Scary Development Every AI Investor Needs to Take Note OfMicron surged over 500% in the past year, Intel climbed more than 250%, and AMD soared over 250% - but a $194 ...Weiss Ratings | SponsoredAnalyst nicknamed “The Prophet” issues new warning for AmericaWhitney Tilson exposed a major company on 60 Minutes in an Emmy-winning investigation - the stock lost nearly ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Chemed Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Chemed With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
